Scientists have developed a novel ‘contact lens’ patch as an alternative to current methods of treating glaucoma and macular degeneration. Could this potentially replace eye drops and conventional eye injections in the future?
#contactlenses... https://t.co/bObFh97bxy
The EU has approved Novartis’ #genetherapy, Luxturna, to restore vision loss in patients with a rare hereditary retinal dystrophies. This reinforces the potential of gene therapy in treating a wide-range of challenging diseases. hashtag#novartis... https://t.co/JQotGh4Q9J
The EU has approved Novartis’ #genetherapy, Luxturna, to restore vision loss in patients with a rare hereditary retinal dystrophies. This reinforces the potential of gene therapy in treating a wide-range of challenging diseases. #novartis
https://t.co/JQotGh4Q9J
Scientists have developed a novel ‘contact lens’ patch as an alternative to current methods of treating glaucoma and macular degeneration. Could this potentially replace eye drops and conventional eye injections in the future?
#contactlenses#ophthalmology
https://t.co/bObFh97bxy
We could be seeing the introduction of tactile expiry date indicators in the UK that could help tackle food waste. This was originally designed for partially sighted people, however research shows that it has wider reaching benefits
#eyehealth#foodlabels https://t.co/L3Re866CdA
Researchers have developed an exciting smart drainage device that extends the effectiveness of implants used to manage glaucoma #eye#glaucoma#medicaltechnology https://t.co/FL3i96fHxp
It’s world diabetes day! This years theme is The Family and Diabetes. Family play an important role in the management, care, prevention and education of diabetes. Visit https://t.co/Yb0dtqVrUL and get involved! #WDD2018#diabetes@WDD
Today is World Diabetes Day! Did you know that it is celebrated on November 14 because it marks the birthday of Sir Frederick Banting, who co-discovered insulin in 1921? Almost 100 years since the discovery, insulin remains out of reach for many #WDD2018 https://t.co/seJvEFp9xR
Novartis’ brolucizumab, one of the most clinically advanced single-chain antibody fragments to date, has shown promising two-year trial results for the treatments of patients with neovascular AMD #eye#AMD#Novartis https://t.co/v73PY2iyrg
Phase II trials of Roche’s faricimab are showing potential in alleviating the compliance burden on patients with neovascular AMD, compared with current anti-VEGF monotherapies #ophthalmology#eye#AMD https://t.co/JEeN3fLlv9
It’s good to see that a high level of growth and investment is being put into the Optical Imaging Market, especially with the rise in eye-related complications with an ageing population #ophthalmology#opticalimagingtechnology#healthcare https://t.co/in0UIjLPqy
Perhaps we should stop naming illnesses and describe ailments according to molecular pathway aberrations. Click here to read more...https://t.co/OrCxuYOWjt
https://t.co/ICjOcwnfUl
World Diabetes Day is tomorrow! This year's theme is Women and diabetes - our right to a healthy future. Visit https://t.co/7CAJIt0JJa … and get involved! #WDD#diabetes
World Diabetes Day is on 14th November. This year's theme is Women and diabetes - our right to a healthy future. Visit https://t.co/7CAJIt0JJa and get involved! #WDD#diabetes